Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

March 8, 2012

Bristol-Myers Squibb divulges new products to treat HIV infection

March 6, 2012

Galen acquires chemotherapy agent from Gilead

Feb. 27, 2012

Scripps Research Institute receives funds to develop new HIV inhibitors

Feb. 27, 2012

Canadian distribution agreement set for tesamorelin

Feb. 22, 2012

Bionor provides update on development of HIV vaccine

Feb. 16, 2012

FDA grants priority review to Truvada sNDA

Feb. 14, 2012

Janssen Pharma seeks Japanese approval of Edurant

Feb. 7, 2012

Novel antiviral agents disclosed by Gilead Sciences

Feb. 3, 2012

Gilead Sciences discloses new agents for HIV infection

Feb. 1, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...